---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-21-018648"
form_type: "8-K"
ticker: "NRC"
cik: "0000070487"
company_name: "NRC HEALTH"
filed_at: "2021-08-05T23:59:59+00:00"
generated_at: "2026-06-29T22:03:29.735312+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# National Research Q2 revenue up 17% to $36.4M; EPS rises to $0.35 from $0.30

## Summary
- Total Recurring Contract Value grew 5% YoY to $149.8M.
- Operating income increased 32% to $12.2M; net income $8.9M vs $7.7M.
- Voice of the Customer revenue up 29% YoY; new clients include The Oregon Clinic and Foundation Health Partners.
- Cash balance $48.9M; management plans to use liquidity for M&A and dividends.
- Diluted EPS $0.35 for Q2 2021, up from $0.30 in Q2 2020.

## SEC filing metadata
- accession: 0001437749-21-018648
- form_type: 8-K
- ticker: NRC
- cik: 0000070487
- company_name: NRC HEALTH
- filed_at: 2021-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70487/000143774921018648/0001437749-21-018648-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70487/000143774921018648/nrc20210802_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-21-018648
- JSON: https://secwatch.observer/filing/0001437749-21-018648.json
- Plain text: https://secwatch.observer/filing/0001437749-21-018648.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.